Ads
related to: lupus and covid 19 vaccine spikevax booster- CDC Health Equity Info.
Learn how CDC prioritizes health &
vaccine equity for minority groups.
- COVID Vaccine Benefits
Learn from CDC about the many
benefits of the COVID vaccines.
- COVID Variant Information
Learn about the COVID variants.
Explore CDC facts and information.
- FDA-Approved Vaccines
Review FDA-approved vaccines.
Get vaccine details & information.
- CDC Health Equity Info.
Search results
Results from the WOW.Com Content Network
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA).
In March 2020, the Food and Drug Administration approved clinical trials for the Moderna COVID‑19 vaccine candidate, and in December, the vaccine, mRNA-1273, was issued an emergency use authorization in the United States. [35] [36] In 2022, it gained FDA approval both for the monovalent vaccine, Spikevax, and a bivalent booster. [37]
The Moderna COVID-19 vaccine, also known as Spikevax, [318] is an mRNA vaccine [319] produced by the American company Moderna, the U.S. National Institute of Allergy and Infectious Diseases, the U.S. Biomedical Advanced Research and Development Authority, and the Coalition for Epidemic Preparedness Innovations.
Refreshed boosters are “the best protection against COVID-19 related hospitalization and death,” the CDC said in a Tuesday news release on its decision. The vaccine also reduces your chances ...
An important application is the development of mRNA vaccines, of which the first authorized were COVID-19 vaccines (such as Comirnaty and Spikevax). Background A ...
Millions more Americans are closer to getting a COVID-19 booster as influential government advisers on Thursday endorsed extra doses of all three of the nation's vaccines — and opened the ...
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials , logistics, and manufacturing.
Earlier this month, the health regulator approved updated COVID-19 vaccines made by Pfizer and Moderna targeting the KP.2 variant. JN.1 was the dominant strain in the United States earlier this year.
Ads
related to: lupus and covid 19 vaccine spikevax booster